|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 5.680 SEK | -2.74% |
|
-11.25% | +184.00% |
| 11-17 | Analysguiden sees increased opportunities for Alzecure | FW |
| 11-11 | AlzeCure Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALZECURE PHARMA AB | Bio Therapeutic Drugs | -2.74% | -11.25% | +184.00% | +187.59% | -14.71% | 76.68M |
- Stock Market
- Stocks
- ALZCUR Stock
- Charts AlzeCure Pharma AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















